Finland· FI-EU-EU/1/96/026/001
Invirase
A saquinavir product, registered in Finland by Roche Registration GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Saquinavir is registered in 6 of 19 countries.
Countries holding a registration under ATC J05AE01 (saquinavir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Saquinavir · ATC J05AE01
6 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Manufacturer
- Roche Registration GmbH
- Country
- Finland (FI)
- ATC code
- J05AE01
- ATC class
- Saquinavir
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- June 4, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
470 interactions on record for saquinavir.
Graded by severity as the source publishes them — 215 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Saquinavir · interactions on record
470 records
- 215 severe
- 199 moderate
- 9 minor
- 29 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
18 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AE01
Saquinavir, as other registers publish it.
- FinlandFortovaseRoche Registration Limited
- United KingdomFortovase 200mg capsulesRoche Products Ltd
- FinlandInviraseRoche Registration GmbH
- FinlandInviraseRoche Registration GmbH
- PolandInviraseRoche Registration GmbH
- FinlandInviraseParanova Oy
- DenmarkInviraseRoche Registration GmbH
- PolandInviraseRoche Registration GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b8d8405-bcfa-4574-96df-05dd58cc4f4e GET /v1/drugs/6b8d8405-bcfa-4574-96df-05dd58cc4f4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.8",
"form": "kapseli, kova",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "sakinaviiri",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/96/026/001",
"fimea_rel_id": "REL3794",
"authorised_at": "1996-10-04"
}See everything about saquinavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.